ArticleIDCases2025
Dengue in older inpatients in the post-COVID-19 Period: a case series from a North Indian tertiary center.
Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Studies on dengue in older patients are scarce from India. The patterns of dengue in the post-COVID-19 period have been poorly studied globally. Our case series describes the patterns and outcomes of dengue in inpatients of the geriatric unit of a tertiary university hospital in North India during the period of August -December 2023. Twenty-four patients were diagnosed with dengue out of 182 admissions during the study period (13.2 %). The median (Q1-Q3) age of patients was 67.5 (64.75-75) years. Fever was present in all except one patient (95.8 %). Weakness, vomiting, dyspnea, and altered sensorium occurred in 41.7 %, 37.5 %, 29.2 %, and 20.8 %, respectively. Hyponatremia, thrombocytopenia, and anemia were observed in 58.3 %, 45.8 %, and 25 % of cases, and nearly one-third developed hepatitis. Leucopenia rates were relatively low. Dengue was severe in two-thirds, and acute kidney injury was the commonest complication. Three fatalities were observed
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.